Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18514932rdf:typepubmed:Citationlld:pubmed
pubmed-article:18514932lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18514932lifeskim:mentionsumls-concept:C0025962lld:lifeskim
pubmed-article:18514932lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:18514932lifeskim:mentionsumls-concept:C0264716lld:lifeskim
pubmed-article:18514932lifeskim:mentionsumls-concept:C0205100lld:lifeskim
pubmed-article:18514932lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:18514932lifeskim:mentionsumls-concept:C0205088lld:lifeskim
pubmed-article:18514932pubmed:issue5lld:pubmed
pubmed-article:18514932pubmed:dateCreated2008-6-2lld:pubmed
pubmed-article:18514932pubmed:abstractTextSkeletal muscle microcirculation impairment in patients with chronic heart failure (CHF) seems to correlate with disease severity. We evaluated the microcirculation by near-infrared spectroscopy (NIRS) occlusion technique before and after inotropic infusion.lld:pubmed
pubmed-article:18514932pubmed:languageenglld:pubmed
pubmed-article:18514932pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18514932pubmed:citationSubsetIMlld:pubmed
pubmed-article:18514932pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18514932pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18514932pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18514932pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18514932pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18514932pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18514932pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18514932pubmed:statusMEDLINElld:pubmed
pubmed-article:18514932pubmed:monthJunlld:pubmed
pubmed-article:18514932pubmed:issn1532-8414lld:pubmed
pubmed-article:18514932pubmed:authorpubmed-author:RoussosCharis...lld:pubmed
pubmed-article:18514932pubmed:authorpubmed-author:NanasSerafimSlld:pubmed
pubmed-article:18514932pubmed:authorpubmed-author:NanasJohnJlld:pubmed
pubmed-article:18514932pubmed:authorpubmed-author:PierrakosChar...lld:pubmed
pubmed-article:18514932pubmed:authorpubmed-author:DimopoulosSta...lld:pubmed
pubmed-article:18514932pubmed:authorpubmed-author:Anastasiou-Na...lld:pubmed
pubmed-article:18514932pubmed:authorpubmed-author:VenetsanakosJ...lld:pubmed
pubmed-article:18514932pubmed:authorpubmed-author:SarafoglouSer...lld:pubmed
pubmed-article:18514932pubmed:authorpubmed-author:KaldaraElissa...lld:pubmed
pubmed-article:18514932pubmed:authorpubmed-author:GerovasiliVas...lld:pubmed
pubmed-article:18514932pubmed:authorpubmed-author:KourtidouSoul...lld:pubmed
pubmed-article:18514932pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18514932pubmed:volume14lld:pubmed
pubmed-article:18514932pubmed:ownerNLMlld:pubmed
pubmed-article:18514932pubmed:authorsCompleteYlld:pubmed
pubmed-article:18514932pubmed:pagination400-6lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:meshHeadingpubmed-meshheading:18514932...lld:pubmed
pubmed-article:18514932pubmed:year2008lld:pubmed
pubmed-article:18514932pubmed:articleTitleInotropic agents improve the peripheral microcirculation of patients with end-stage chronic heart failure.lld:pubmed
pubmed-article:18514932pubmed:affiliationPulmonary and Critical Care Medicine Department, Cardiopulmonary Exercise Testing and Rehabilitation Laboratory, Evgenidio Hospital, Athens, Greeece.lld:pubmed
pubmed-article:18514932pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18514932pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18514932lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18514932lld:pubmed